Table 1.
Patient demographic, clinical and biochemical features
| Demographics | Median (range) or Number (%) (n=15) |
|---|---|
| Age (yr) | 58 (52-68) |
|
| |
| Females | 5/15 (33%) |
|
| |
| Compensated cirrhosis (Child A) | 3 /15 (20%) |
|
| |
| Decompensated cirrhosis (Child B&C) | 12/15 (80%) |
|
| |
| Etiology of liver disease | |
| NASH | 6 (40%) |
| PSC | 3 (20%) |
| Alcoholic | 2 (13.2%) |
| HCV/HBV | 1 (6.7%) |
| PBC | 1 (6.7%) |
| Autoimmune hepatitis | 1 (6.7%) |
| Drugs | 1 (6.7%) |
|
| |
| Ascites | 12/15 (80%) |
|
| |
| Splenomegaly | 10/15 (66.6%) |
|
| |
| Esophageal varices | 9/15 (60%) |
|
| |
| Coexisting cancer | 4/15 (26%) |
|
| |
| Platelet count × 106/L | 80 (45-204) |
|
| |
| Total bilirubin (mg/dl) | 4.3 (1.4-5) |
|
| |
| Albumin (g/dl) | 3.4 (3.1- 3.7) |
|
| |
| Alanine aminotransferase (U/L) | 58 (26-81) |
|
| |
| Aspartate aminotransferase (U/L) | 61.5 (36.5-93.5) |
|
| |
| Alkaline phosphatase (U/L) | 160 (88-293) |
|
| |
| INR | 1.3 (1.2-1.3) |
|
| |
| Liver biopsy | 7 (47%) |
|
| |
| US abdomen | 13 (87%) |
|
| |
| CT abdomen | 12 (80%) |
|
| |
| EGD | 11 (73%) |
|
| |
| Beta-blocker | 4 (27%) |